Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Mid-range Performer

Download real time

1044.60 -19.50 (-1.83%)

27.55% Gain from 52W Low

226.8K NSE+BSE Volume

NSE 15 May, 2026 3:31 PM (IST)

12,821.4

Market Cap

High in industry

-

Beta 1Year

Very Low volatility

Alivus Life Sciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ALIVUS, BSE:543322 Alivus Life Sciences Ltd.

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

133 Votes:

Buy 75.19%

Sell 12.03%

Hold 12.78%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >